UBS Group Cuts Synchrony Financial (NYSE:SYF) Price Target to $81.00
UBS Group has lowered its price target for Synchrony Financial (NYSE:SYF) to $81.00 from $87.00, while maintaining a "neutral" rating, suggesting a potential upside of 12.6% from its current price of $71.93. Despite this, Synchrony Financial holds a "Moderate Buy" consensus rating from analysts with an average target price of $88.57, driven by nine Buy ratings and six Hold ratings. The company recently reported strong quarterly earnings per share of $2.59, surpassing estimates by $0.45, with revenues of $3.72 billion.
Upstart Jumps 6% as Its Own Macro Index Ticks Down; Synchrony Financial Holds Flat, OneMain Holdings Barely Budges
Upstart's stock jumped 6% after its proprietary Upstart Macro Index, which gauges credit stress, dipped slightly to 1.49, signaling a modest improvement in credit conditions. This rally appears specific to Upstart, as other consumer lenders like Synchrony Financial and OneMain Holdings showed little movement. While the index improvement is positive for Upstart's AI-driven lending model, the index remains above normal levels, and a sustained trend of decline is needed to confirm a broader shift in the credit environment.
Upstart Jumps 6% as Its Own Macro Index Ticks Down; Synchrony Financial Holds Flat, OneMain Holdings Barely Budges
Upstart (UPST) stock surged 6% after its proprietary Upstart Macro Index, a credit-stress gauge, slightly dipped to 1.49, signaling a modest improvement in credit conditions for the first time since early 2022. This rally was company-specific, as competitor lenders Synchrony Financial and OneMain Holdings remained flat, indicating that the market views the improvement as unique to Upstart's AI-driven lending model. While the dip suggests a positive direction, the index remains elevated, and sustained declines are needed to establish a long-term trend of improving credit health.
Synchrony Financial stock enters October with Q3 results set for October 20
Synchrony Financial (SYF) stock was trading at USD 71.89 on October 5, 2026, ahead of its Q3 2026 earnings release scheduled for October 20. The company reported strong Q2 results with diluted EPS of USD 2.59, beating consensus, and analysts maintain a "Moderate Buy" rating with an average 12-month target of USD 88.25. The upcoming Q3 report will be crucial for assessing purchase and loan growth alongside credit loss management within the company's fiscal 2026 EPS guidance of USD 9.25-9.50.
UBS Adjusts Price Target on Synchrony Financial to $81 From $87, Keeps Neutral Rating
UBS has adjusted its price target for Synchrony Financial (SYF) to $81, down from $87, while maintaining a Neutral rating on the stock. This update comes amidst other recent analyst adjustments for the consumer lending company. Goldman Sachs also revised its price target to $82 from $87, but held a Buy rating, and Evercore ISI cut its target to $80 from $86 while keeping an Outperform rating.
The Venmo Credit Card Now Pays Up to 4% Cash Back When You Split with Friends
Venmo has announced an update to its credit card, allowing users to earn up to 4% cash back on dining and entertainment purchases, including an additional 1% when they split transactions with friends on the Venmo app. This industry-first "split-to-earn" feature is designed to reward cardholders for their social spending habits. The card, issued by Synchrony on the Visa network, comes with no annual fee, no foreign transaction fees, and daily cash back deposits directly into the cardholder's Venmo account.
Will Vet Software Financing Deal Change Synchrony Stock Narrative
Synchrony Financial's CareCredit brand has partnered with Vetspire, integrating financing directly into AI-driven veterinary software. While this move enhances Synchrony's embedded finance strategy, it doesn't significantly alter the company's risk-reward balance or its forecast of declining earnings over the next three years. The success of this integration will depend on execution data from participating clinics, which could impact revenue growth and credit costs.
Synchrony announces third-quarter results timing as Synchrony Financial stock trades EUR 63.77
Synchrony Financial announced it would report its third-quarter 2026 results on October 20, 2026, with an earnings release and conference call scheduled for that day. The company's stock was trading at EUR 63.77 in weekend trading at Lang & Schwarz on October 4, 2026, unchanged from its last Xetra close. Investors can access the earnings release, presentation materials, and webcast via Synchrony's investor relations website.
ETFs Investing in Synchrony Financial Stocks
This article lists various Exchange Traded Funds (ETFs) that hold Synchrony Financial (SFE) stocks, providing details such as market value, weight, issuer, management style, expense ratio, and assets under management. It highlights how these funds can make investing in stocks more accessible and offer opportunities with lower risk. The data presented covers a range of ETFs from major financial institutions like Vanguard, BlackRock, and State Street, categorizing them by their investment focus (e.g., total market, large cap, mid cap, financials).
19,868 Synchrony Financial $SYF Shares Acquired by CX Institutional
CX Institutional significantly increased its stake in Synchrony Financial (NYSE:SYF) by 33.7%, purchasing 19,868 shares to bring its total holdings to 78,791 shares valued at approximately $5.6 million. This acquisition highlights continued strong institutional ownership in Synchrony Financial, with other major firms also modifying their positions. The company recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend, contributing to a "Moderate Buy" consensus rating from analysts.
Synchrony Financial Director Reports Acquisition of 846 Restricted Stock Units
A Synchrony Financial director, Parker P.W., acquired 846 restricted stock units (RSUs) of Synchrony Financial common stock on September 30, 2026. The RSUs were acquired at $70.97 per unit and are scheduled to vest fully on September 30, 2027. This transaction increased the director's direct beneficial ownership to 35,333 shares.
Director receives 846 stock units at Synchrony Financial (SYF), vesting September 30, 2027.
Synchrony Financial director Arthur W. Coviello Jr. was awarded 846 restricted stock units on September 30, 2026. These units, valued at $70.97 per share, will vest in full on September 30, 2027, and represent a contingent right to receive one share of common stock per unit. Following this transaction, Coviello's direct holdings in Synchrony Financial totaled 27,012 shares.
A director receives 846 stock units at Synchrony Financial (SYF), vesting September 30, 2027.
Synchrony Financial director Daniel O. Colao acquired 846 restricted stock units on September 30, 2026. These units, each representing a contingent right to one common share, are scheduled to vest in full on September 30, 2027. Following this transaction, Colao's direct holdings in Synchrony Financial totaled 6,528 shares.
A director receives 1,287 stock units at Synchrony Financial (SYF); they vest September 30, 2027.
Synchrony Financial director Jeffrey G. Naylor acquired 1,287 restricted stock units on September 30, 2026. These units are set to vest in full on September 30, 2027, with each unit representing a contingent right to receive one share of Synchrony Financial common stock. Following this transaction, Naylor's direct position in the company stands at 66,904 shares.
An 846-unit stock grant goes to director Ellen M. Zane at Synchrony Financial (SYF).
Synchrony Financial director Ellen M. Zane was granted 846 restricted stock units (RSUs) on September 30, 2026. These RSUs represent a contingent right to receive common shares and will vest in full on September 30, 2027. Following this award, Zane's direct holdings in Synchrony Financial totaled 33,087 shares.
Synchrony Deepens CareCredit's Veterinary Reach With Vetspire Tie-Up
Synchrony Financial is enhancing its CareCredit veterinary payment options by integrating them directly into Vetspire’s AI-enabled practice management platform. This partnership aims to streamline financing within the clinical workflow for over 1,000 veterinary hospitals, reducing reliance on separate payment terminals and making financing more accessible. The collaboration also presents an opportunity to increase CareCredit adoption among Vetspire's customer base and provides participating practices with marketing resources and business intelligence support.
Evercore ISI Cuts Synchrony Financial Price Target to $80 From $86, Maintains Outperform Rating
Evercore ISI has lowered its price target for Synchrony Financial (NYSE: SYF) to $80 from $86, while reiterating an "Outperform" rating on the stock. This adjustment comes amidst other analyst actions on Synchrony, including recent price target changes from UBS, Deutsche Bank, Seaport Global, and Goldman Sachs. The article also notes recent strategic partnerships and AI initiatives by Synchrony Financial.
Synchrony Deepens CareCredit's Veterinary Reach With Vetspire Tie-Up
Synchrony (SYF) is expanding its CareCredit veterinary payment services by integrating with Vetspire's AI-enabled practice management platform. This partnership aims to streamline payment processing and financing options directly within the clinical workflow for veterinary practices, potentially increasing treatment acceptance and improving efficiency. The collaboration also offers Vetspire's clinics access to CareCredit's marketing and business intelligence resources, with plans to measure the impact on workflow and treatment acceptance.
From deferred repairs to done deals: Why flexible financing matters in auto service
This article by Keith Mait discusses the importance of flexible financing options in the auto service industry. It highlights how offering such financing can help customers avoid deferring necessary repairs, leading to more completed deals for service providers.
Credit Card Stocks Q2 In Review: Capital One (NYSE:COF) Vs Peers
This article reviews the Q2 performance of several credit card stocks, highlighting Capital One (NYSE:COF), Bread Financial (NYSE:BFH), American Express (NYSE:AXP), Synchrony Financial (NYSE:SYF), and Mastercard (NYSE:MA). Capital One reported strong revenue growth in line with expectations, while Bread Financial outperformed analysts' estimates. American Express showed the weakest performance against estimates, and Synchrony Financial had the slowest revenue growth.
Analysts Offer Insights on Financial Companies: Synchrony Financial (SYF) and Northern (NTRS)
Wells Fargo analyst Donald Fandetti reiterated a Buy rating on Synchrony Financial (SYF) with an $88.00 price target, highlighting a 25.4% upside based on the moderate buy consensus. Separately, Wells Fargo analyst Mike Mayo assigned a Hold rating to Northern (NTRS) with a $194.00 price target, noting a 5.3% upside from current levels according to the general analyst consensus. Both analyses contribute to recent coverage in the Financial sector.
Credit Card Stocks Q2 In Review: Capital One (NYSE:COF) Vs Peers
This article reviews the Q2 performance of several credit card stocks, highlighting Capital One (COF), Bread Financial (BFH), American Express (AXP), Synchrony Financial (SYF), and Mastercard (MA). It details their revenue growth, performance against analyst expectations, and subsequent stock price movements. While most saw strong quarters in some aspects, many experienced stock declines post-earnings.
How Can Trust Shape Synchrony Financial's AI Shopping Opportunity?
Synchrony Financial's study with Oxford Economics suggests that consumer trust, characterized by security, transparency, control, and recourse, is crucial for the adoption of AI in shopping, rather than mere convenience. Consumers are more comfortable using AI for low-risk tasks, and data security and transparency are prioritized over time savings. As AI integration progresses, particularly for payments and larger purchases, the company emphasizes robust safeguards and features to maintain its role in digital commerce, aiming to boost card usage, financing, and partner engagement.
Synchrony Financial stock underperforms Wednesday when compared to competitors
Synchrony Financial (SYF) stock fell 1.05% on Wednesday, closing at $70.97. This performance was in contrast to the broader market, which also saw declines with the S&P 500 down 0.25% and the Dow Jones Industrial Average falling 0.86%. The company's stock is currently 20.05% below its 52-week high.
Synchrony Financial's Quarterly Earnings Preview: What You Need to Know
Synchrony Financial (SYF) is preparing to announce its fiscal Q3 2026 results on October 20, with analysts forecasting a 16.8% drop in profit per share compared to the previous year. Despite a recent stock underperformance relative to the S&P 500, analysts hold a "Moderate Buy" rating for SYF, predicting a potential upside of 24.3%. Concerns about declining late fee incidents, net interest margin pressure, and elevated customer payment rates contributed to a 1.6% stock fall in July, though full-year EPS guidance was raised.
About 85% of Vetspire's 1,000+ veterinary practices use CareCredit. Financing will move into their system.
Synchrony's CareCredit has partnered with Vetspire to integrate its financing options directly into Vetspire's AI-enabled, cloud-based veterinary practice management software. This collaboration aims to streamline payment processes for veterinary teams, reduce administrative burden, and make financing options more accessible for pet owners at the point of care. The integration deepens an existing relationship, as approximately 85% of Vetspire's 1,000+ veterinary practices are already CareCredit-enrolled providers.
Synchrony Financial stock reports a Q2 EPS beat before October 20
Synchrony Financial (SYF) reported a Q2 EPS of USD 2.59, surpassing the USD 2.14 consensus estimate, with revenue matching expectations at USD 3.72 billion. The company has set its fiscal 2026 EPS guidance between USD 9.25 and USD 9.50, and analysts have a "Moderate Buy" rating with a target price of USD 88.25. Investors are awaiting the Q3 2026 results, scheduled for October 20, 2026, before the US market opens.
Consumers prefer AI shopping with strong securi...
New research by Synchrony and Oxford Economics indicates that consumers are more likely to use AI for shopping when robust protections like fraud prevention, data security, and transparency are in place. While consumers trust AI for low-risk tasks such as price comparisons, they are hesitant for high-value purchases without strong safeguards. Synchrony is working to build this trust by focusing on control, transparency, and protection to expand AI commerce adoption.
Synchrony and Oxford Economics Find Trust Will Define the Future of AI Shopping
A new study by Synchrony and Oxford Economics indicates that consumer trust, driven by clear protection, transparency, and control, will be crucial for the widespread adoption of AI in online shopping. The research highlights that while consumers are comfortable with AI for low-risk tasks like searching and comparing, they demand robust security and fraud protection for higher-value purchases, and existing trusted relationships play a significant role in their willingness to delegate shopping tasks to AI. Businesses are advised to prioritize protection, transparency, and consumer control to build confidence in AI commerce.
Best CD rates today, Wednesday, September 30, 2026: Earn up to 4.40% APY with Happen Bank and Synchrony Bank
CD rates are currently high due to recent Federal Reserve rate hikes, with the best short-term CDs offering 4% to 4.5% APY. Happen Bank and Synchrony Bank lead with a 4.40% APY. It's a good time to consider short-term CDs for competitive interest while protecting savings from market risks, and comparing offers from online banks and credit unions is advised.
Synchrony Premier World Mastercard®
This article provides an overview of the Synchrony Premier World Mastercard®, highlighting key statistics based on Credit Karma member data. It details the average credit limit, credit score, credit utilization, age, and annual income of members who have matched with this card or similar ones. The content also notes that the card has no annual fee and is reviewed by Intuit Credit Karma's Editorial team.
Synchrony Financial stock at USD 71.52 on September 28, 2026, down 1.95 percent
Synchrony Financial's stock closed at USD 71.52 on September 28, 2026, marking a 1.95 percent decrease from the previous session. The company is scheduled to release its third-quarter 2026 financial results on October 20, with earnings and presentation materials available at 6:00 a.m. Eastern Time, followed by a conference call at 8:00 a.m. Eastern Time.
Synchrony Financial (SYF) Expands Into AI Commerce, Is The Stock Cheap?
Synchrony Financial (SYF) is expanding its presence in embedded finance through new collaborations with Intelibly Inc. for its CareCredit offering and OpenAI for AI shopping tools. Despite recent stock volatility, the company's long-term performance remains strong, and analysts view SYF as 18% undervalued with a fair value of $89.22. These digital partnerships and AI investments are seen as crucial for risk management and operational efficiency, though potential risks from losing major retail partners or regulatory costs remain.
How Dental Financing Integration Will Impact Synchrony Financial (SYF) Investors
Intelibly Inc. has partnered with Synchrony Financial to embed the CareCredit health and wellness credit card into Intelibly’s dental appointment platform, providing patients with early financing options. This integration aims to capture more dental spending for Synchrony Financial, which is already pursuing a broader embedded finance strategy with major partners. While this move supports Synchrony's existing focus on health and wellness financing, the company's investment narrative still hinges on overall receivables growth and the performance of larger partner programs amid forecast earnings decline.
Synchrony Financial stock falls 1.41 percent as targets stay above price
Synchrony Financial's stock fell 1.41% to USD 71.91 on September 28, 2026, despite beating Q2 2026 EPS consensus with USD 2.59 against USD 2.14. Analysts maintain a "Moderate Buy" rating with an average 12-month target of USD 88.25, 22.72% above the current price. The company has also set fiscal 2026 EPS guidance at USD 9.25-9.50 and will report Q3 results on October 20, 2026.
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Find Risky
This article identifies one stock, Synchrony Financial (SYF), as having exciting potential, aligning with Wall Street's optimistic price targets due to strong earnings and balance sheet growth. Conversely, it flags Fiserv (FISV) and Provident Financial Services (PFS) as risky, citing growth challenges, declining profitability, and poor returns on equity or tangible book value, despite Wall Street's higher price targets. The analysis aims to provide unbiased investment insights by contrasting analyst consensus with StockStory's independent assessment.
How Dental Financing Integration Will Impact Synchrony Financial (SYF) Investors
Synchrony Financial (SYF) is partnering with Intelibly Inc. to embed its CareCredit health and wellness credit card into Intelibly’s dental appointment platform, providing patients with financing options earlier in their care journey. This integration aligns with Synchrony's broader strategy of embedded finance, as seen with Amazon, Walmart, and PayPal, and is viewed as another test of this approach. While it is not expected to immediately transform the short-term earnings outlook, it could shift more dental spending towards Synchrony Financial's health and wellness vertical.
Synchrony Financial Share Price - SYF, RNS News, Articles, Quotes, & Charts (NYSE:SYF)
This article provides a company overview for Synchrony Financial (NYSE: SYF), a consumer financial services company offering various credit products. It includes current market data such as the share price, market capitalization, and 52-week high/low, alongside recent news and related articles from Proactive Investors. The company's subsidiary, Synchrony Bank, provides private label, dual, co-brand, and general-purpose credit cards, as well as installment loans and savings products.
Pinnacle Financial Partners is the No. 1 Best Place to Work for Women
Pinnacle Financial Partners has been ranked as the No. 1 Best Place to Work for Women nationwide in 2026 by Best Companies Group, marking its first appearance in the enterprise category. This recognition is based on feedback and survey data directly from employees. The firm emphasizes that being a best place to work is integral to its vision, fostering an environment where team members are passionate and contribute to extraordinary performance.
Why Is Synchrony Financial (NYSE:SYF) Among S&P 500 Financials?
Synchrony Financial (NYSE:SYF) is a significant component of the S&P 500 Financials sector, primarily focusing on consumer finance. The company operates through partner-based models, offering credit and banking products across various retail, health, and wellness segments, with its CareCredit platform being central to healthcare financing. Synchrony's distinct position is driven by its specialized approach to consumer credit, healthcare financing, and expanding digital integrations.
Why Is Magnolia Oil & Gas Corporation (MGY) Suddenly a Must-Watch Midcap Stocks Name?
Magnolia Oil & Gas Corporation (MGY) has become a focal point in the Midcap Stocks sector after completing the WildFire Energy acquisition, expanding its South Texas position. This development places the company under scrutiny regarding its execution, commercial response, and operational discipline in a changing energy landscape. Investors are advised to observe subsequent disclosures for consistent delivery and economic translation of this strategic move.
What's Behind MIRA Pharmaceuticals, Inc.'s (MIRA) Big Moment in Cannabis Stocks?
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is gaining attention in the cannabis stocks sector due to the completion of dose-range toxicology work for MIRA-Fifty-Five, an oral candidate designed for inflammatory pain. This development positions MIRA to modulate cannabinoid receptor pathways, prompting investors to assess the company's execution capabilities, customer response, and broader sector conditions. The article emphasizes that sustained operational delivery, rather than initial headlines, will determine MIRA's long-term success in the competitive Cannabis Stocks market.
Can Synchrony Financial (SYF) Stay Reasonable After A 146% Run?
Synchrony Financial (SYF) has experienced a significant share price increase of 146.4% over the past three years but has recently seen a pullback, prompting a review of its valuation. The company's P/E ratio of 6.8x is below industry averages, suggesting it might be undervalued, a perspective supported by some analysts' intrinsic value estimates of around $145 per share. A new partnership integrating CareCredit into Intelibly’s dental platform is expected to support future earnings from health-focused lending.
Synchrony Financial stock heads into the open after a 1.2 percent gain
Synchrony Financial stock gained 1.2 percent on the NYSE on September 24, 2026, closing at USD 72.48. This performance outpaced the Russell 2000, which increased by 0.6 percent on the same day. The stock traded between USD 71.62 and USD 72.91 with a volume of 2,184,306 shares.
Pinnacle grows deposits by triple digits in Baltimore MSA
Pinnacle Financial Partners significantly grew deposits in the Baltimore MSA, achieving a 141% increase to $134 million as of June 30, 2026, primarily from its Columbia, MD, office. This growth reflects the strength of its local team and relationship-building efforts. The company, which merged with Synovus in January 2026, also showed strong deposit growth across its footprint and maintains top positions in several markets.
Synchrony Financial stock gains 1.24 percent on NYSE
Synchrony Financial stock traded at USD 71.55 on the NYSE, marking a 1.24 percent increase. Despite the gain, the stock remains 19.4 percent below its 52-week high of USD 88.77. The company reported second-quarter net earnings of USD 885 million, with net interest income rising 2 percent and purchase volume up 8 percent year-over-year.
NexMetals Mining Announces Botswana Selebi Main Drill Results in SEC Filing
NexMetals Mining Corp. filed a Form 8-K with the SEC, reporting assay results from drill hole SMD-26-219 and a new visual intercept from drill hole SMD-26-217 at its Selebi Main deposit in Botswana. The company clarified its adherence to Canadian National Instrument 43-101 (NI 43-101) for mineral resource terminology and SEC mining disclosure regulations (S-K 1300). CFO Brett MacKay authorized the filing, which was submitted under Regulation FD Disclosure.
Pinnacle Financial Partners grows market share in Florida
Pinnacle Financial Partners has significantly increased its market share in Florida, particularly in Jacksonville and Orlando, following its 2026 merger with Synovus. The firm achieved double-digit pro forma combined deposit growth in these key markets, with Jacksonville entering the top 10 for market share. This growth is attributed to client trust and the continued efforts of local teams in building relationships and integrating operations.
Pinnacle Financial Partners gains market share, places No. 5 in Alabama
Pinnacle Financial Partners has expanded its market share in Alabama following its merger with Synovus, achieving $8.2 billion in local deposits and ranking No. 5 statewide with 5.7% market share. The firm is recognized as the fastest-growing financial institution in Mobile and holds top positions in several other MSAs across the Southeast. These results highlight successful integration and continued client trust and team member recruitment.
Atlanticus Holdings Corporation (ATLC) stock price, news, quote and history
This article provides a comprehensive overview of Atlanticus Holdings Corporation (ATLC), a financial technology company specializing in credit services and auto finance. It details the company's stock performance, financial data including revenue and earnings, and analyst ratings. The report highlights the company's CaaS and Auto Finance segments, product offerings, and key financial metrics, alongside a performance comparison with the S&P 500.
